Medication Safety in Intravenous Therapy: Compatibility of Etoposide With Frequently Drugs Used in Tumour Critical Care During Simulated Y-Site Administration [Corrigendum]
Ding H, Tong T, Liu S, Tang L, Chen Z. Drug Des Devel Ther. 2025;19:1147—1161. The authors have advised there is an error in Figure 1 on page 1151. The text “Particles > 25 µm≤25 particles/mL” should read “Partic...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-03-01
|
| Series: | Drug Design, Development and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/corrigendum-medication-safety-in-intravenous-therapy-compatibility-of--peer-reviewed-fulltext-article-DDDT |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Ding H, Tong T, Liu S, Tang L, Chen Z. Drug Des Devel Ther. 2025;19:1147—1161.
The authors have advised there is an error in Figure 1 on page 1151. The text “Particles > 25 µm≤25 particles/mL” should read “Particles > 25 µm≤ 3 particles/mL”. The correct Figure 1 is as follows.
Figure 1 Diagram of compatibility justification.
The authors apologize for this error. |
|---|---|
| ISSN: | 1177-8881 |